Menu Search
Equities

BrainCool AB (publ)

5YL:DEU

BrainCool AB (publ)

Actions
  • Price (EUR)0.135
  • Today's Change-0.002 / -1.46%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BrainCool AB (publ) is a Sweden-based medical device company, that specializes in the development, marketing, and sale of medical cooling systems of the human brain. The Company's technology acts as cooling pads that are applied to different parts of the patient's body, where the system controls the body temperature and other movements. Its product portfolio includes the BrainCool System, Cooral System, and RhinoChill System, offering a range of medical cooling solutions. The combination of the BrainCool and RhinoChill Systems provides care solution from pre-hospital to patient discharge. Cooral System offers solution for improving patients' quality of life and presents healthcare providers with an effective means of oral mucositis reduction. The products are used in the treatment of various severe conditions such as stroke, cardiac arrest, concussion, and migraine.

  • Revenue in SEK (TTM)37.48m
  • Net income in SEK-57.58m
  • Incorporated2010
  • Employees20.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.